Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study.
Adv Med Sci. 2014 Sep;59(2):256-60. doi: 10.1016/j.advms.2014.03.003. Epub 2014 Jun 10.
Adv Med Sci. 2014.
PMID: 25105662
Clinical Trial.
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease.
Lizakowski S, Tylicki L, Renke M, Rutkowski P, Heleniak Z, Sławińska-Morawska M, Aleksandrowicz-Wrona E, Małgorzewicz S, Rutkowski B.
Lizakowski S, et al. Among authors: slawinska morawska m.
Am J Hypertens. 2012 Jun;25(6):636-9. doi: 10.1038/ajh.2012.14. Epub 2012 Feb 23.
Am J Hypertens. 2012.
PMID: 22357413
Clinical Trial.
Item in Clipboard
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial.
Lizakowski S, Tylicki L, Renke M, Rutkowski P, Heleniak Z, Sławińska-Morawska M, Aleksandrowicz E, Łysiak-Szydłowska W, Rutkowski B.
Lizakowski S, et al. Among authors: slawinska morawska m.
Int Urol Nephrol. 2012 Dec;44(6):1763-70. doi: 10.1007/s11255-011-0110-z.
Int Urol Nephrol. 2012.
PMID: 23326865
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite